209 related articles for article (PubMed ID: 9373247)
1. Synergistic action of Flt3 and gp130 signalings in human hematopoiesis.
Ebihara Y; Tsuji K; Lyman SD; Sui X; Yoshida M; Muraoka K; Yamada K; Tanaka R; Nakahata T
Blood; 1997 Dec; 90(11):4363-8. PubMed ID: 9373247
[TBL] [Abstract][Full Text] [Related]
2. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells.
Sui X; Tsuji K; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2859-63. PubMed ID: 7535932
[TBL] [Abstract][Full Text] [Related]
3. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208
[TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling.
Sui X; Tsuji K; Ebihara Y; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
Blood; 1999 Apr; 93(8):2525-32. PubMed ID: 10194431
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous activation of signals through gp130, c-kit, and interleukin-3 receptor promotes a trilineage blood cell production in the absence of terminally acting lineage-specific factors.
Kimura T; Sakabe H; Tanimukai S; Abe T; Urata Y; Yasukawa K; Okano A; Taga T; Sugiyama H; Kishimoto T; Sonoda Y
Blood; 1997 Dec; 90(12):4767-78. PubMed ID: 9389693
[TBL] [Abstract][Full Text] [Related]
6. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
7. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein 130 and c-kit signals synergistically induce thrombopoietin production by hematopoietic cells.
Matsui A; Sato T; Maekawa T; Asano S; Nakahata T; Tsuji K
Int J Hematol; 2000 Dec; 72(4):455-62. PubMed ID: 11197211
[TBL] [Abstract][Full Text] [Related]
9. Role of glycoprotein 130 and c-Kit signaling in proliferation and differentiation of human hematopoietic progenitor cells.
Nakahata T; Sui X; Tanaka R; Tajima S; Muraoka K; Ebihara Y; Tsuji K
Cancer Chemother Pharmacol; 1996; 38 Suppl():S64-8. PubMed ID: 8765420
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-independent erythrocyte production: signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells.
Sui X; Tsuji K; Tajima S; Tanaka R; Muraoka K; Ebihara Y; Ikebuchi K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
J Exp Med; 1996 Mar; 183(3):837-45. PubMed ID: 8642288
[TBL] [Abstract][Full Text] [Related]
11. GP130 and c-kit signalling, initiated by the sIL-6R/IL-6 complex, is insufficient to expand the primitive adult bone marrow CD34+CD38- pre-CFU cell.
Van Bockstaele DR; Nijs G; Lenjou M; Bosmans E; Vanham G; Rodrigus I; Berneman ZN
Ann Hematol; 2000 Dec; 79(12):667-71. PubMed ID: 11195003
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
[TBL] [Abstract][Full Text] [Related]
13. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
[TBL] [Abstract][Full Text] [Related]
14. Combined signaling through interleukin-7 receptors and flt3 but not c-kit potently and selectively promotes B-cell commitment and differentiation from uncommitted murine bone marrow progenitor cells.
Veiby OP; Lyman SD; Jacobsen SE
Blood; 1996 Aug; 88(4):1256-65. PubMed ID: 8695843
[TBL] [Abstract][Full Text] [Related]
15. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
[TBL] [Abstract][Full Text] [Related]
16. Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells.
McKenna HJ; de Vries P; Brasel K; Lyman SD; Williams DE
Blood; 1995 Nov; 86(9):3413-20. PubMed ID: 7579445
[TBL] [Abstract][Full Text] [Related]
17. Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct.
Gotze KS; Ramirez M; Tabor K; Small D; Matthews W; Civin CI
Blood; 1998 Mar; 91(6):1947-58. PubMed ID: 9490677
[TBL] [Abstract][Full Text] [Related]
18. FLK-2/FLT-3 ligand regulates the growth of early myeloid progenitors isolated from human fetal liver.
Muench MO; Roncarolo MG; Menon S; Xu Y; Kastelein R; Zurawski S; Hannum CH; Culpepper J; Lee F; Namikawa R
Blood; 1995 Feb; 85(4):963-72. PubMed ID: 7531516
[TBL] [Abstract][Full Text] [Related]
19. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
20. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
